Skip to main content

Prenetics Global Ltd

For the period ended Nov 5, 2026. Filed Nov 5, 2026.

View on SEC.gov

About this filing

What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.

Nov 5, 2026 · Filed Nov 5, 2026

Use the contents to explore the available documents and sections.

PRE$15.94-1.1%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

EX-99.2 · (a)Consideration

(a)Consideration.

(i)Guaranteed Minimum Royalties. As consideration for the rights granted herein, Company shall pay to ABG-CB “Guaranteed Minimum Royalty(ies)” (also referred to herein as “GMR(s)”) which shall be defined as non-returnable advances recoupable against Royalties earned in the same Contract Year.

For each Contract Year during the Initial Term, the GMR shall be:

Contract YearGuaranteed Minimum Royalty
1 (2026)$[***] USD
2 (2027-2029)$[***] USD
3 (2030)$[***] USD
4 (2031)$[***] USD
5 (2032)$[***] USD
6 (2033)$[***] USD
7 (2034)$[***] USD
8 (2035)$[***] USD
9 (2036)$[***] USD

Company hereby acknowledges that the GMR is payable to ABG-CB even if Company fails to manufacture, sell or market the Licensed Products during the Term, and is a condition of ABG-CB entering into this Agreement.

(ii)Royalty. Company shall pay ABG-CB the Royalty(ies) quarterly, within forty five (45) days of the end of each Calendar Quarter.

(iii)Equity. As additional consideration for Contract Years 2 – 9, Prenetics Global Limited shall issue to ABG-CB shares of common stock of Prenetics Global Limited (listed on the Nasdaq Stock Market under the ticker symbol "PRE") (the "Equity Consideration"), having an aggregate value of [] United States Dollars (US $[]), valued based on the Reference Price (defined below) (the "Grant Date Value") as further described below.

The Equity Consideration shall vest [] percent ([]%) on each December 31 of each calendar year during the Term, starting in calendar year 2027 (the "Vesting Period").

The number of shares comprising the Equity Consideration shall be determined by [] (the "Reference Price"), which is $[]. For the avoidance of doubt, the Reference Price is [***]. The grant of the Equity Consideration shall be pursuant to, and subject to the terms of, that certain share subscription agreement to be entered into between Prenetics Global Limited and ABG-CB on or around the date of execution of this Agreement (the “Share Subscription Agreement”).

(iv)Free Units. Company shall ship, at Company’s sole cost, a case of each Licensed Products to ABG-CB each Contract Year.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.